Bausch Health Companies Profile

91911KAP7   97.00  3.00  3.00%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Default

Below Average

 
High
 
Low
VALEANT PHARMACEUTICALS INTL INC CDA 9 percent 15Dec2025 is a Senior Unsecured Note issued by the corporate entity on the 4th of December 2017. Bausch is trading at 97.00 as of the 25th of March 2025, a 3 percent decrease since the beginning of the trading day. The bond's open price was 100.0. Bausch has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.

Moving against Bausch Bond

  0.68AMBR Amber Road, Symbol ChangePairCorr
  0.45GTN Gray TelevisionPairCorr
  0.37SPNT Siriuspoint Normal TradingPairCorr
  0.35TKOMF Tokio Marine HoldingsPairCorr
  0.32ISMAY Indra Sistemas SAPairCorr
  0.32GDXU MicroSectors Gold MinersPairCorr

Bausch Bond Highlights

Business ConcentrationBausch Health Companies Corporate Bond, Industrial, Manufacturing (View all Sectors)
Sub Product AssetCORP
Next Call Date15th of December 2022
Coupon Payment FrequencySemi-Annual
CallableYes
Sub Product Asset TypeCorporate Bond
NameVALEANT PHARMACEUTICALS INTL INC CDA 9 percent 15Dec2025
C U S I P91911KAP7
Offering Date4th of December 2017
Coupon9.0
Debt TypeSenior Unsecured Note
I S I NUS91911KAP75
Issuer CountryCanada
Yield To Maturity14.727
Price89.53
Bausch Health Companies (91911KAP7) is traded in USA.

Bausch Health Companies Risk Profiles

Bausch Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bausch without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Other Information on Investing in Bausch Bond

Bausch financial ratios help investors to determine whether Bausch Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bausch with respect to the benefits of owning Bausch security.